Sunset Capital Assets Acquires Aphex BioCleanse Systems

July 31, 2020

Sunset Capital Assets Inc. completed a share exchange to acquire Aphex BioCleanse Systems Inc., effective July 31, 2020. The transaction resolved prior judicial liens on the predecessor balance sheet and Sunset will operate forward as Aphex, continuing commercialization of the company's Hy‑IQ disinfectant formulation.

Buyers
Sunset Capital Assets Inc.
Targets
Aphex BioCleanse Systems Inc.
Industry
Manufacturing
Location
New York, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.